ZEOX (Zeo ScientifiX) FCF Margin %: -7.83% (As of Apr. 2026)


ZEOX Zeo ScientifiX Inc ZEOX
50 GF Score
Price $1.75
GF Value $2.67
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Zeo ScientifiX FCF Margin %?

Zeo ScientifiX ZEOX +2.94% 50 FCF Margin % is -7.83% as of Apr. 2026. GuruFocus rates ZEOX with a GF Score™ of 50/100 and a GF Value™ of $2.67 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 960 Biotechnology companies, Zeo ScientifiX ranks better than 63.65% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Zeo ScientifiX's Free Cash Flow for the three months ended in Apr. 2026 was $-0.20 Mil. Zeo ScientifiX's Revenue for the three months ended in Apr. 2026 was $2.58 Mil. Therefore, Zeo ScientifiX's FCF Margin % for the quarter that ended in Apr. 2026 was -7.83%.

As of today, Zeo ScientifiX's current FCF Yield % is -9.67%.

The historical rank and industry rank for Zeo ScientifiX's FCF Margin % or its related term are showing as below:

ZEOX' s FCF Margin % Range Over the Past 10 Years
Min: -310.27   Med: -54.53   Max: -14.25
Current: -18.99


During the past 13 years, the highest FCF Margin % of Zeo ScientifiX was -14.25%. The lowest was -310.27%. And the median was -54.53%.

ZEOX's FCF Margin % is ranked better than
63.65% of 960 companies
in the Biotechnology industry
Industry Median: -85.21 vs ZEOX: -18.99


Zeo ScientifiX FCF Margin % Related Terms


Zeo ScientifiX FCF Margin % Historical Data

* Premium members only.

The historical data trend for Zeo ScientifiX's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zeo ScientifiX FCF Margin % Chart

Zeo ScientifiX Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -55.48 -61.49 -48.77 -31.39 -14.25

Zeo ScientifiX Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.45 -19.68 -23.16 -33.54 -7.83

ZEOX vs LNAI, GDTC, HOOK: FCF Margin % Comparison

For the Biotechnology subindustry, Zeo ScientifiX's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zeo ScientifiX FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zeo ScientifiX's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Zeo ScientifiX's FCF Margin % falls into.


ZEOX
50GF Score
Zeo ScientifiX Inc ZEOX
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zeo ScientifiX FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Zeo ScientifiX's FCF Margin for the fiscal year that ended in Oct. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Oct. 2025 )/Revenue (A: Oct. 2025 )
=-0.741/5.199
=-14.25 %

Zeo ScientifiX's FCF Margin for the quarter that ended in Apr. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Apr. 2026 )/Revenue (Q: Apr. 2026 )
=-0.202/2.581
=-7.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -7.83% mean?
Zeo ScientifiX (ZEOX) has a FCF Margin % of -7.83% as of Apr. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Zeo ScientifiX and its competitors. According to the industry distribution chart, Zeo ScientifiX ranks #349 out of 960 companies in the Biotechnology industry, placing it in the top 36.4%.
Is Zeo ScientifiX's FCF Margin % too high?
Zeo ScientifiX's current FCF Margin % is -7.83%. Based on the distribution chart, Zeo ScientifiX ranks #349 out of 960 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Zeo ScientifiX has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Zeo ScientifiX's FCF Margin % compare to LNAI and GDTC?
According to the Biotechnology industry distribution chart, Zeo ScientifiX ranks #349 out of 960 companies for FCF Margin %. This puts Zeo ScientifiX in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Zeo ScientifiX and its competitors. Zeo ScientifiX's current FCF Margin % is -7.83%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zeo ScientifiX stock overvalued right now?
Based on GuruFocus' analysis, Zeo ScientifiX (ZEOX) is currently considered Possible Value Trap. The stock's GF Value™ is $2.67, compared to a current price of $1.75 — trading 34.5% below its estimated fair value. The current FCF Margin % is -7.83%. Zeo ScientifiX's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Zeo ScientifiX (ZEOX), the current FCF Margin % is -7.83% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zeo ScientifiX (ZEOX) Overvalued in 2026?

Based on GuruFocus' analysis, Zeo ScientifiX stock appears to be undervalued. The current stock price of $1.75 is trading 34.5% below its estimated GF Value™ of $2.67. GuruFocus considers Zeo ScientifiX to be Possible Value Trap.

Key valuation signals for ZEOX:

  • FCF Margin %: -7.83%
  • GF Value™: $2.67 vs. price of $1.75 (34.5% below fair value)
  • GF Score™: 50/100 with 4 warning signs

No single metric tells the full story. See the ZEOX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Zeo ScientifiX Business Description

Address 3321 College Avenue, Suite 246, Davie, FL, USA, 33314
Zeo ScientifiX Inc is a clinical-stage biopharmaceutical company located inside Nova Southeastern University's Collaborative Center for Research in Davie, Florida. The Company is a clinical-stage biopharmaceutical company principally focusing on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicine. The Company's proprietary products, including Zofin, are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, proteins and cell secreted nanoparticles and Patient Pure X (PPX ), an autologous biologic containing a nanoparticle fraction that is precipitated from a patient's own peripheral blood (RAAM Products).
50GF Score

Get the complete analysis for ZEOX

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.75
Price
$2.67
GF Value